ASTX660 Uses, Dosage, Side Effects and more
ASTX660 is under investigation in clinical trial NCT02503423 (Phase 1-2 Study of ASTX660 in Subjects With Advanced Solid Tumors and Lymphomas).
| Trade Name | ASTX660 |
| Generic | ASTX660 |
| Type | |
| Formula | C30H42FN5O3 |
| Weight | Average: 539.696 Monoisotopic: 539.327168395 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
